The overarching goal of this PPG is to understand the role of the kidney in the pathogenesis of hypertension, a major cause of global mortality and a primary modifiable risk factor for renal, cardiovascular and cerebrovascular disease. Approximately half of all hypertensive subjects demonstrate sodium-sensitivity of blood pressure, the mechanisms of which are poorly understood. Several important discoveries from the investigators of this program provide unique conceptual insight into the development of salt-sensitive hypertension and renal damage and form the basis for this proposal. The integrated hypothesis of our program is that salt-induced hypertension proceeds in two phases. An initial, or primary, increase in blood pressure (BP) is followed by a more dramatic, secondary rise of BP that is dependent upon the initial increase in renal perfusion pressure (RPP) and culminates in `malignant hypertension' and renal end-organ damage. This global hypothesis will be tested in three projects which are exploring previously unrecognized areas of importance in hypertension. One entirely new area of research, to be examined in Project 1, is focused around the mechanisms of action of mTOR pathways in salt- sensitive hypertension and the potential therapeutic use of mTOR inhibition as a novel therapeutic strategy to treat hypertension. Project 2 is testing the innovative hypothesis that alterations in cellular metabolism, specifically insufficiencies in fumarase-related metabolism in the kidney, contribute to hypertension by decreasing arginine regeneration and nitric oxide levels. Project 3 is based upon the unique observation made in the current PPG indicating that an initial elevation in renal perfusion pressure is necessary to mediate the infiltration of immune cells into the kidney which amplifies the disease process; the proposed experiments will elucidate the molecular transduction of this physical force. To facilitate this important work, the projects are supported by an administrative core (Core A), and two scientific cores, which have been specially designed to meet the needs of the program and facilitate an economy of resources. Core B will supply the unique genetic animal models which have been generated to address the particular hypotheses of the scientific projects. Core C will provide many of the unique scientific approaches that will be used in the projects. Together, the three integrated projects and three cores of this PPG will provide important new information and insight into the mechanisms of salt-sensitive hypertension in a collaborative research effort that will accelerate the acquisition of knowledge more effectively than a simple aggregate of research projects that have no interaction or thematic integration.
The work in this PPG is designed to understand the role of the kidney in development of hypertension, which is the leading identifiable cause of death worldwide and a major risk factor for a number of related cardiovascular and renal diseases in the US. This program will examine the role of three, previously unexamined mechanisms which lead to the development and maintenance of sodium-sensitive hypertension. Specifically, the studies address the complex interrelationship between factors important in regulation of sodium excretion, cell growth and proliferation, mechanisms regulating cellular metabolism, and the immune system in the development of hypertension. The scientific projects that address these unique concepts will be supported by scientific core facilities which provide unique animal models and experimental approaches and methodologies to aid in these studies.
|Kumar, Vikash; Wollner, Clayton; Kurth, Theresa et al. (2017) Inhibition of Mammalian Target of Rapamycin Complex 1 Attenuates Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats. Hypertension 70:813-821|
|Mattson, David L; Liang, Mingyu (2017) Hypertension: From GWAS to functional genomics-based precision medicine. Nat Rev Nephrol 13:195-196|
|Abais-Battad, Justine M; Dasinger, John Henry; Fehrenbach, Daniel J et al. (2017) Novel adaptive and innate immunity targets in hypertension. Pharmacol Res 120:109-115|
|Evans, Louise C; Petrova, Galina; Kurth, Theresa et al. (2017) Increased Perfusion Pressure Drives Renal T-Cell Infiltration in the Dahl Salt-Sensitive Rat. Hypertension 70:543-551|
|Hashmat, Shireen; Rudemiller, Nathan; Lund, Hayley et al. (2016) Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats. Am J Physiol Renal Physiol 311:F555-61|
|Cowley Jr, Allen W; Yang, Chun; Zheleznova, Nadezhda N et al. (2016) Evidence of the Importance of Nox4 in Production of Hypertension in Dahl Salt-Sensitive Rats. Hypertension 67:440-50|
|Dayton, Alex; Exner, Eric C; Bukowy, John D et al. (2016) Breaking the Cycle: Estrous Variation Does Not Require Increased Sample Size in the Study of Female Rats. Hypertension 68:1139-1144|
|Huang, Baorui; Cheng, Yuan; Usa, Kristie et al. (2016) Renal Tumor Necrosis Factor ? Contributes to Hypertension in Dahl Salt-Sensitive Rats. Sci Rep 6:21960|
|Miller, Bradley; Palygin, Oleg; Rufanova, Victoriya A et al. (2016) p66Shc regulates renal vascular tone in hypertension-induced nephropathy. J Clin Invest 126:2533-46|
|Zheleznova, Nadezhda N; Yang, Chun; Cowley Jr, Allen W (2016) Role of Nox4 and p67phox subunit of Nox2 in ROS production in response to increased tubular flow in the mTAL of Dahl salt-sensitive rats. Am J Physiol Renal Physiol 311:F450-8|
Showing the most recent 10 out of 29 publications